These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 11913538

  • 1. Lafutidine changes levels of somatostatin, calcitonin gene-related peptide, and secretin in human plasma.
    Itoh H, Naito T, Takeyama M.
    Biol Pharm Bull; 2002 Mar; 25(3):379-82. PubMed ID: 11913538
    [Abstract] [Full Text] [Related]

  • 2. Calcitonin gene-related peptide and somatostatin releases correlated with the area under the lafutidine concentration-time curve in human plasma.
    Ikawa K, Shimatani T, Azuma Y, Inoue M, Morikawa N.
    J Clin Pharm Ther; 2006 Aug; 31(4):351-6. PubMed ID: 16882104
    [Abstract] [Full Text] [Related]

  • 3. Lafutidine, a newly developed antiulcer drug, elevates postprandial intragastric pH and increases plasma calcitonin gene-related peptide and somatostatin concentrations in humans: comparisons with famotidine.
    Shimatani T, Inoue M, Kuroiwa T, Xu J, Nakamura M, Tazuma S, Ikawa K, Morikawa N.
    Dig Dis Sci; 2006 Jan; 51(1):114-20. PubMed ID: 16416222
    [Abstract] [Full Text] [Related]

  • 4. Lafutidine, a novel histamine H2-receptor antagonist, increases serum calcitonin gene-related peptide in rats after water immersion-restraint stress.
    Sato H, Kawashima K, Yuki M, Kazumori H, Rumi MA, Ortega-Cava CF, Ishihara S, Kinoshita Y.
    J Lab Clin Med; 2003 Feb; 141(2):102-5. PubMed ID: 12577045
    [Abstract] [Full Text] [Related]

  • 5. [Clinicopharmacological study of gastrointestinal drugs from the viewpoint of postmarketing development].
    Itoh H.
    Yakugaku Zasshi; 2006 Sep; 126(9):767-78. PubMed ID: 16946590
    [Abstract] [Full Text] [Related]

  • 6. Effects of mosapride citrate on human plasma levels of motilin, gastrin, somatostatin, and secretin.
    Itoh H, Nagano T, Takeyama M.
    Biol Pharm Bull; 2001 Sep; 24(9):1072-5. PubMed ID: 11558572
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of neutrophil activation by lafutidine, an H2-receptor antagonist, through enhancement of sensory neuron activation contributes to the reduction of stress-induced gastric mucosal injury in rats.
    Harada N, Okajima K.
    Dig Dis Sci; 2007 Feb; 52(2):469-77. PubMed ID: 17211693
    [Abstract] [Full Text] [Related]

  • 8. Sensitizing effects of lafutidine on CGRP-containing afferent nerves in the rat stomach.
    Nishihara K, Nozawa Y, Nakano M, Ajioka H, Matsuura N.
    Br J Pharmacol; 2002 Mar; 135(6):1487-94. PubMed ID: 11906962
    [Abstract] [Full Text] [Related]

  • 9. Omeprazole raises somatostatin and motilin in human plasma.
    Katagiri F, Inoue S, Itoh H, Takeyama M.
    Biol Pharm Bull; 2005 Feb; 28(2):370-3. PubMed ID: 15684503
    [Abstract] [Full Text] [Related]

  • 10. Dual effect of lafutidine on the gut and liver.
    Kaneko H.
    J Gastroenterol Hepatol; 2003 Mar; 18(3):237-8. PubMed ID: 12603521
    [No Abstract] [Full Text] [Related]

  • 11. Lafutidine increases hepatic blood flow via potentiating the action of central thyrotropin-releasing hormone in rats.
    Yoneda M, Kurosawa M, Watanobe H, Terano A.
    J Gastroenterol Hepatol; 2003 Feb; 18(2):177-84. PubMed ID: 12542603
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Early effects of oral administration of lafutidine with mosapride compared with lafutidine alone on intragastric pH values.
    Iida H, Inamori M, Nozaki Y, Endo H, Hosono K, Akiyama T, Sakamoto Y, Takahashi H, Koide T, Tokoro C, Abe Y, Nakajima A.
    BMC Gastroenterol; 2009 Jul 09; 9():52. PubMed ID: 19589146
    [Abstract] [Full Text] [Related]

  • 14. Effects of Ninjin-to on levels of brain-gut peptides (motilin, vasoactive intestinal peptide, gastrin, and somatostatin) in human plasma.
    Naito T, Itoh H, Nagano T, Takeyama M.
    Biol Pharm Bull; 2001 Feb 09; 24(2):194-6. PubMed ID: 11217092
    [Abstract] [Full Text] [Related]

  • 15. Protective effect of lafutidine, a histamine H2 receptor antagonist, against loxoprofen-induced small intestinal lesions in rats.
    Amagase K, Ochi A, Sugihara T, Kato S, Takeuchi K.
    J Gastroenterol Hepatol; 2010 May 09; 25 Suppl 1():S111-8. PubMed ID: 20586851
    [Abstract] [Full Text] [Related]

  • 16. Ecabet sodium raises plasma levels of calcitonin generelated peptide and substance P in healthy humans.
    Katagiri F, Inoue S, Sato Y, Itoh H, Takeyama M.
    J Pharm Pharmacol; 2005 Jun 09; 57(6):799-805. PubMed ID: 15969937
    [Abstract] [Full Text] [Related]

  • 17. Effect of Sho-hange-ka-bukuryo-to on gastrointestinal peptide concentrations in the plasma of healthy human subjects.
    Katagiri F, Itoh H, Takeyama M.
    Biol Pharm Bull; 2004 Oct 09; 27(10):1674-8. PubMed ID: 15467218
    [Abstract] [Full Text] [Related]

  • 18. Intestinal protection by lafutidine, a histamine H(2)-receptor antagonist, against indomethacin-induced damage in rats--role of endogenous nitric oxide.
    Tanaka A, Mizoguchi H, Hase S, Miyazawa T, Takeuchi K.
    Med Sci Monit; 2001 Oct 09; 7(5):869-77. PubMed ID: 11535926
    [Abstract] [Full Text] [Related]

  • 19. Comparison of effect of an increased dosage of vonoprazan versus vonoprazan plus lafutidine on gastric acid inhibition and serum gastrin.
    Suzuki T, Kagami T, Uotani T, Yamade M, Hamaya Y, Iwaizumi M, Osawa S, Sugimoto K, Miyajima H, Furuta T.
    Eur J Clin Pharmacol; 2018 Jan 09; 74(1):45-52. PubMed ID: 28986609
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetic and pharmacodynamic properties of lafutidine after postprandial oral administration in healthy subjects: comparison with famotidine.
    Ikawa K, Shimatani T, Hayato S, Morikawa N, Tazuma S.
    Biol Pharm Bull; 2007 May 09; 30(5):1003-6. PubMed ID: 17473452
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.